Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN)

CUSIP: 83548R204

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM NEW
Shares outstanding
6,190,476
Total 13F shares
142
Share change
-4,300,811
Total reported value
$28
Price per share
$0.20
Number of holders
1
Value change
-$2,106,519
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 83548R204?
CUSIP 83548R204 identifies SONN - Sonnet BioTherapeutics Holdings, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) as of Q3 2023

As of 30 Sep 2023, Sonnet BioTherapeutics Holdings, Inc. - COM NEW (SONN) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 142 shares. The largest 1 holders included IFP Advisors, Inc. This page lists 1 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.